• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多重耐药性人KB癌细胞系中药物蓄积减少。

Reduced drug accumulation in multiply drug-resistant human KB carcinoma cell lines.

作者信息

Fojo A, Akiyama S, Gottesman M M, Pastan I

出版信息

Cancer Res. 1985 Jul;45(7):3002-7.

PMID:4005839
Abstract

Human KB cells with increasing resistance to colchicine and other chemotherapeutic agents have been isolated in four sequential steps. This report describes the characterization of drug uptake in the parent and four mutant cell lines. Drug uptake in these cell lines occurred via a nonsaturable process. In general, drug accumulation decreased with increasing drug resistance; this relationship was seen best with colchicine, vincristine, vinblastine, and daunomycin and, to a lesser extent, with actinomycin D. The accumulation of dexamethasone, an agent to which all lines were equally sensitive, was similar for the parent and the four mutants. Drug efflux occurred rapidly, and differences among the various cell lines could be detected within the first minute. In the more resistant lines, a greater percentage of the drug was released more rapidly, although the absolute amount of drug released was less. Verapamil partially reversed the multiple drug-resistance phenotype by increasing the initial rate of uptake and accumulation of drugs in the resistant cell lines without an apparent effect on drug efflux. The results suggest that, in this human epithelial cell, the development of resistance to multiple drugs is complex, with changes in drug uptake, accumulation, and efflux.

摘要

已通过四个连续步骤分离出对秋水仙碱和其他化疗药物耐药性不断增加的人KB细胞。本报告描述了亲代细胞系和四个突变细胞系中药物摄取的特征。这些细胞系中的药物摄取通过非饱和过程发生。一般来说,药物积累随着耐药性的增加而减少;秋水仙碱、长春新碱、长春花碱和柔红霉素的这种关系最为明显,放线菌素D的这种关系则较弱。所有细胞系对其敏感性相同的地塞米松在亲代细胞和四个突变体中的积累情况相似。药物外排迅速,在第一分钟内就能检测到不同细胞系之间的差异。在耐药性更强的细胞系中,尽管释放的药物绝对量较少,但更大比例的药物释放得更快。维拉帕米通过提高耐药细胞系中药物的初始摄取率和积累,部分逆转了多药耐药表型,而对药物外排没有明显影响。结果表明,在这种人类上皮细胞中,对多种药物耐药性的产生是复杂的,涉及药物摄取、积累和外排的变化。

相似文献

1
Reduced drug accumulation in multiply drug-resistant human KB carcinoma cell lines.多重耐药性人KB癌细胞系中药物蓄积减少。
Cancer Res. 1985 Jul;45(7):3002-7.
2
Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and -sensitive KB cells: effects of verapamil and other drugs.多药耐药和敏感KB细胞中柔红霉素摄取与外排的单细胞分析:维拉帕米及其他药物的作用
Cancer Res. 1986 Nov;46(11):5941-6.
3
Circumvention of multiple-drug resistance in human cancer cells by thioridazine, trifluoperazine, and chlorpromazine.
J Natl Cancer Inst. 1986 May;76(5):839-44.
4
Reversal of multidrug resistance by synthetic isoprenoids in the KB human cancer cell line.
Cancer Res. 1986 Sep;46(9):4453-7.
5
Reduced daunomycin accumulation in drug-sensitive and multidrug-resistant human carcinoma KB cells following phorbol ester treatment: a potential role for protein kinase C in reducing drug influx.佛波酯处理后,药物敏感和多药耐药的人KB癌细胞中柔红霉素蓄积减少:蛋白激酶C在减少药物内流中的潜在作用
Oncol Res. 1996;8(6):249-57.
6
Effect of Stemona curtisii root extract on P-glycoprotein and MRP-1 function in multidrug-resistant cancer cells.宽叶百部属根提取物对多药耐药癌细胞中P-糖蛋白和多药耐药相关蛋白1功能的影响。
Phytomedicine. 2007 Jun;14(6):381-9. doi: 10.1016/j.phymed.2007.03.006. Epub 2007 Apr 30.
7
Transport of cisplatin and bis-acetato-ammine-dichlorocyclohexylamine Platinum(IV) (JM216) in human ovarian carcinoma cell lines: identification of a plasma membrane protein associated with cisplatin resistance.顺铂和双乙酸-氨-二氯环己胺铂(IV)(JM216)在人卵巢癌细胞系中的转运:一种与顺铂耐药相关的质膜蛋白的鉴定
Clin Cancer Res. 1995 Sep;1(9):981-9.
8
Energy-dependent reduced drug binding as a mechanism of Vinca alkaloid resistance in human leukemic lymphoblasts.能量依赖的药物结合减少作为人白血病淋巴母细胞中长春花生物碱耐药性的一种机制。
Mol Pharmacol. 1983 Nov;24(3):485-92.
9
Decreased accumulation of [14C]carboplatin in human cisplatin-resistant cells results from reduced energy-dependent uptake.[14C]卡铂在人顺铂耐药细胞中的蓄积减少是由于能量依赖性摄取减少所致。
J Cell Physiol. 2000 Apr;183(1):108-16. doi: 10.1002/(SICI)1097-4652(200004)183:1<108::AID-JCP13>3.0.CO;2-4.
10
Inhibition of P-glycoprotein activity and reversal of cancer multidrug resistance by Momordica charantia extract.苦瓜提取物对P-糖蛋白活性的抑制及癌症多药耐药性的逆转
Cancer Chemother Pharmacol. 2004 Dec;54(6):525-30. doi: 10.1007/s00280-004-0848-4. Epub 2004 Jul 10.

引用本文的文献

1
The Resistance of Cancer Cells to Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, is Mediated by the ABCB1 Transporter.癌细胞对细胞周期蛋白依赖性激酶4/6抑制剂帕博西尼的耐药性由ABCB1转运蛋白介导。
Front Pharmacol. 2022 Mar 8;13:861642. doi: 10.3389/fphar.2022.861642. eCollection 2022.
2
Targeting P-glycoprotein: Investigation of piperine analogs for overcoming drug resistance in cancer.靶向 P-糖蛋白:胡椒碱类似物克服癌症耐药性的研究。
Sci Rep. 2017 Aug 11;7(1):7972. doi: 10.1038/s41598-017-08062-2.
3
The Role of Multidrug Resistance Efflux Pumps in Cancer: Revisiting a JNCI Publication Exploring Expression of the MDR1 (P-glycoprotein) Gene.
多药耐药外排泵在癌症中的作用:重新审视一篇《国家癌症研究所杂志》关于探索MDR1(P-糖蛋白)基因表达的出版物
J Natl Cancer Inst. 2015 Aug 18;107(9). doi: 10.1093/jnci/djv222. Print 2015 Sep.
4
Dual properties of hispidulin: antiproliferative effects on HepG2 cancer cells and selective inhibition of ABCG2 transport activity.滨蓟黄素的双重特性:对肝癌细胞HepG2的抗增殖作用及对ABCG2转运活性的选择性抑制
Mol Cell Biochem. 2015 Nov;409(1-2):123-33. doi: 10.1007/s11010-015-2518-8. Epub 2015 Jul 26.
5
Proteome analysis of multidrug-resistant, breast cancer-derived microparticles.多药耐药性乳腺癌来源的微粒体蛋白质组分析。
J Extracell Vesicles. 2014 Aug 22;3. doi: 10.3402/jev.v3.24384. eCollection 2014.
6
Abcb4 acts as multixenobiotic transporter and active barrier against chemical uptake in zebrafish (Danio rerio) embryos.Abcb4 作为多药物外排转运体和活性屏障,可防止斑马鱼(Danio rerio)胚胎吸收化学物质。
BMC Biol. 2013 Jun 17;11:69. doi: 10.1186/1741-7007-11-69.
7
Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani.利什曼原虫临床分离株中两性霉素 B 耐药的机制。
Antimicrob Agents Chemother. 2012 Feb;56(2):1031-41. doi: 10.1128/AAC.00030-11. Epub 2011 Nov 28.
8
A pharmacodynamic study of docetaxel in combination with the P-glycoprotein antagonist tariquidar (XR9576) in patients with lung, ovarian, and cervical cancer.多西他赛联合 P-糖蛋白拮抗剂 XR9576 治疗肺癌、卵巢癌和宫颈癌患者的药效学研究。
Clin Cancer Res. 2011 Feb 1;17(3):569-80. doi: 10.1158/1078-0432.CCR-10-1725. Epub 2010 Nov 16.
9
A phase I study of the P-glycoprotein antagonist tariquidar in combination with vinorelbine.P-糖蛋白拮抗剂 tariquidar 联合长春瑞滨的 I 期研究。
Clin Cancer Res. 2009 May 15;15(10):3574-82. doi: 10.1158/1078-0432.CCR-08-0938. Epub 2009 May 5.
10
Intracellular localisation studies of doxorubicin and Victoria Blue BO in EMT6-S and EMT6-R cells using confocal microscopy.使用共聚焦显微镜研究阿霉素和维多利亚蓝 BO 在 EMT6-S 和 EMT6-R 细胞中的细胞内定位。
Cytotechnology. 2002 May;39(1):15-25. doi: 10.1023/A:1022435829894.